Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page
- Check5 days agoChange DetectedThe study page now includes a recruitment status note indicating recruitment is closed ('No longer looking for participants'), and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) with an updated Intervention/Treatment label. The previous label 'Intervention / Treatment' and the older 'Revision: v3.5.5' are removed and replaced with 'Revision: v3.6.0'.SummaryDifference0.6%

- Check12 days agoChange DetectedRevision: v3.5.5 appears to replace v3.5.4 in the page metadata, signaling a small update to the page's revision history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows a new revision number (v3.5.4) replacing v3.5.3, indicating a small site update. This change affects metadata rather than any study details.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s footer revision/version has been updated from v3.5.2 to v3.5.3 for the ClinicalTrials.gov site software.SummaryDifference0.1%

- Check62 days agoChange DetectedUpdated the site's release label from Revision: v3.5.0 to Revision: v3.5.2.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded: Revision v3.5.0; Removed: Revision v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.